創傷デブリードマンの世界市場 2023-2027

創傷デブリードマン市場は2022-2027年に4億7,477万米ドル、予測期間中のCAGRは7.31％で成長すると予測されます。

当レポートでは、創傷デブリードマン市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、創傷デブリードマン製品の技術的進歩、急性および慢性創傷の有病率の増加、外科手術量の増加によって牽引されています。

本調査では、創傷デブリードマン治療における遠隔医療利用の増加が、今後数年間の創傷デブリードマン市場成長を牽引する主要因の1つであると特定しています。また、創傷デブリードマンデバイスの適応症の拡大や、銅、銀、金チタン、酸化亜鉛などのナノ粒子の創傷治療への登場は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 創傷デブリードマンの世界市場 2017-2021
• エンドユーザーセグメント分析 2017-2021
• 製品セグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 病院：市場規模と予測 2022-2027
• クリニック：市場規模と予測 2022-2027
• その他：市場規模と予測 2022-2027
• 市場機会：エンドユーザー別

第7章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• 自己分解性：市場規模と予測 2022-2027
• 外科的：市場規模と予測 2022-2027
• 機械式：市場規模と予測 2022-2027
• 酵素：市場規模と予測 2022-2027
• その他：市場規模と予測 2022-2027
• 市場機会：製品別

第8章 顧客情勢

• 顧客情勢の概要

第9章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第10章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第11章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Arobella Medical LLC
• B.Braun SE
• Bioventus LLC
• Coloplast AS
• ConvaTec Group Plc
• Integra Lifesciences Corp.
• Labomar S.p.A
• Lohmann and Rauscher GmbH and Co. KG
• Medaxis AG
• Mediwound Ltd.
• Medline Industries LP
• Molnlycke Health Care AB
• Pulsecare Medical LLC
• Smith and Nephew plc
• Zimmer Biomet Holdings Inc.

第12章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global wound debridement market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on End-user - Market share 2022-2027 (%)
• Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits46: Market opportunity by End-user ($ million)
• Exhibits47: Data Table on Market opportunity by End-user ($ million)
• Exhibits48: Chart on Product - Market share 2022-2027 (%)
• Exhibits49: Data Table on Product - Market share 2022-2027 (%)
• Exhibits50: Chart on Comparison by Product
• Exhibits51: Data Table on Comparison by Product
• Exhibits52: Chart on Autolytic - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Autolytic - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Autolytic - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Autolytic - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Surgical - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Surgical - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Surgical - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Surgical - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Mechanical - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Mechanical - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Mechanical - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Mechanical - Year-over-year growth 2022-2027 (%)
• Exhibits64: Chart on Enzymatic - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Data Table on Enzymatic - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Chart on Enzymatic - Year-over-year growth 2022-2027 (%)
• Exhibits67: Data Table on Enzymatic - Year-over-year growth 2022-2027 (%)
• Exhibits68: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits70: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits71: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits72: Market opportunity by Product ($ million)
• Exhibits73: Data Table on Market opportunity by Product ($ million)
• Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits75: Impact of drivers and challenges in 2022 and 2027
• Exhibits76: Overview on Criticality of inputs and Factors of differentiation
• Exhibits77: Overview on factors of disruption
• Exhibits78: Impact of key risks on business
• Exhibits79: Vendors covered
• Exhibits80: Matrix on vendor position and classification
• Exhibits81: Arobella Medical LLC - Overview
• Exhibits82: Arobella Medical LLC - Product / Service
• Exhibits83: Arobella Medical LLC - Key offerings
• Exhibits84: B.Braun SE - Overview
• Exhibits85: B.Braun SE - Business segments
• Exhibits86: B.Braun SE - Key news
• Exhibits87: B.Braun SE - Key offerings
• Exhibits88: B.Braun SE - Segment focus
• Exhibits89: Bioventus LLC - Overview
• Exhibits90: Bioventus LLC - Business segments
• Exhibits91: Bioventus LLC - Key news
• Exhibits92: Bioventus LLC - Key offerings
• Exhibits93: Bioventus LLC - Segment focus
• Exhibits94: Coloplast AS - Overview
• Exhibits95: Coloplast AS - Business segments
• Exhibits96: Coloplast AS - Key news
• Exhibits97: Coloplast AS - Key offerings
• Exhibits98: Coloplast AS - Segment focus
• Exhibits99: ConvaTec Group Plc - Overview
• Exhibits100: ConvaTec Group Plc - Product / Service
• Exhibits101: ConvaTec Group Plc - Key news
• Exhibits102: ConvaTec Group Plc - Key offerings
• Exhibits103: Integra Lifesciences Corp. - Overview
• Exhibits104: Integra Lifesciences Corp. - Business segments
• Exhibits105: Integra Lifesciences Corp. - Key news
• Exhibits106: Integra Lifesciences Corp. - Key offerings
• Exhibits107: Integra Lifesciences Corp. - Segment focus
• Exhibits108: Labomar S.p.A - Overview
• Exhibits109: Labomar S.p.A - Product / Service
• Exhibits110: Labomar S.p.A - Key offerings
• Exhibits111: Lohmann and Rauscher GmbH and Co. KG - Overview
• Exhibits112: Lohmann and Rauscher GmbH and Co. KG - Product / Service
• Exhibits113: Lohmann and Rauscher GmbH and Co. KG - Key offerings
• Exhibits114: Medaxis AG - Overview
• Exhibits115: Medaxis AG - Product / Service
• Exhibits116: Medaxis AG - Key offerings
• Exhibits117: Mediwound Ltd. - Overview
• Exhibits118: Mediwound Ltd. - Product / Service
• Exhibits119: Mediwound Ltd. - Key offerings
• Exhibits120: Medline Industries LP - Overview
• Exhibits121: Medline Industries LP - Product / Service
• Exhibits122: Medline Industries LP - Key offerings
• Exhibits123: Molnlycke Health Care AB - Overview
• Exhibits124: Molnlycke Health Care AB - Product / Service
• Exhibits125: Molnlycke Health Care AB - Key offerings
• Exhibits126: Pulsecare Medical LLC - Overview
• Exhibits127: Pulsecare Medical LLC - Product / Service
• Exhibits128: Pulsecare Medical LLC - Key offerings
• Exhibits129: Smith and Nephew plc - Overview
• Exhibits130: Smith and Nephew plc - Business segments
• Exhibits131: Smith and Nephew plc - Key news
• Exhibits132: Smith and Nephew plc - Key offerings
• Exhibits133: Smith and Nephew plc - Segment focus
• Exhibits134: Zimmer Biomet Holdings Inc. - Overview
• Exhibits135: Zimmer Biomet Holdings Inc. - Business segments
• Exhibits136: Zimmer Biomet Holdings Inc. - Key news
• Exhibits137: Zimmer Biomet Holdings Inc. - Key offerings
• Exhibits138: Zimmer Biomet Holdings Inc. - Segment focus
• Exhibits139: Inclusions checklist
• Exhibits140: Exclusions checklist
• Exhibits141: Currency conversion rates for US$
• Exhibits142: Research methodology
• Exhibits143: Validation techniques employed for market sizing
• Exhibits144: Information sources
• Exhibits145: List of abbreviations

The wound debridement market is forecasted to grow by USD 474.77 million during 2022-2027, accelerating at a CAGR of 7.31% during the forecast period. The report on the wound debridement market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in wound debridement products, increasing prevalence of acute and chronic wounds, and increasing volume of surgical procedures.

Technavio's wound debridement market is segmented as below:

By End-user

• Hospitals
• Clinics
• Others

By Product

• Autolytic
• Surgical
• Mechanical
• Enzymatic
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing use of telemedicine in wound debridement treatments as one of the prime reasons driving the wound debridement market growth during the next few years. Also, expanding indications of wound debridement devices and emergence of nanoparticles like copper, silver, gold titanium, and zinc oxide to treat wounds will lead to sizable demand in the market.

The report on the wound debridement market covers the following areas:

• Wound debridement market sizing
• Wound debridement market forecast
• Wound debridement market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading wound debridement market vendors that include Arobella Medical LLC, B.Braun SE, BioMonde Ltd., Bioventus LLC, Brightwake Ltd., Coloplast AS, ConvaTec Group Plc, DeRoyal Industries Inc., EZ Debride, Integra Lifesciences Corp., Labomar S.p.A, Lohmann and Rauscher GmbH and Co. KG, Medaxis AG, Mediwound Ltd., Medline Industries LP, Molnlycke Health Care AB, Pulsecare Medical LLC, RLS Global AB, Smith and Nephew plc, and Zimmer Biomet Holdings Inc. Also, the wound debridement market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global wound debridement market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global wound debridement market 2017 - 2021 ($ million)
• 4.2 End-user Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• 4.3 Product Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Hospitals - Market size and forecast 2022-2027
• Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• 6.4 Clinics - Market size and forecast 2022-2027
• Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
• 6.5 Others - Market size and forecast 2022-2027
• Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.6 Market opportunity by End-user
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 48: Chart on Product - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
• 7.2 Comparison by Product
• Exhibit 50: Chart on Comparison by Product
• Exhibit 51: Data Table on Comparison by Product
• 7.3 Autolytic - Market size and forecast 2022-2027
• Exhibit 52: Chart on Autolytic - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Autolytic - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Autolytic - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Autolytic - Year-over-year growth 2022-2027 (%)
• 7.4 Surgical - Market size and forecast 2022-2027
• Exhibit 56: Chart on Surgical - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Surgical - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Surgical - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Surgical - Year-over-year growth 2022-2027 (%)
• 7.5 Mechanical - Market size and forecast 2022-2027
• Exhibit 60: Chart on Mechanical - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Mechanical - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Mechanical - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Mechanical - Year-over-year growth 2022-2027 (%)
• 7.6 Enzymatic - Market size and forecast 2022-2027
• Exhibit 64: Chart on Enzymatic - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Enzymatic - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Enzymatic - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Enzymatic - Year-over-year growth 2022-2027 (%)
• 7.7 Others - Market size and forecast 2022-2027
• Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 7.8 Market opportunity by Product
• Exhibit 72: Market opportunity by Product ($ million)
• Exhibit 73: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Drivers, Challenges, and Trends

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
• Exhibit 75: Impact of drivers and challenges in 2022 and 2027
• 9.4 Market trends

10 Vendor Landscape

• 10.1 Overview
• 10.2 Vendor landscape
• Exhibit 76: Overview on Criticality of inputs and Factors of differentiation
• 10.3 Landscape disruption
• Exhibit 77: Overview on factors of disruption
• 10.4 Industry risks
• Exhibit 78: Impact of key risks on business

11 Vendor Analysis

• 11.1 Vendors covered
• Exhibit 79: Vendors covered
• 11.2 Market positioning of vendors
• Exhibit 80: Matrix on vendor position and classification
• 11.3 Arobella Medical LLC
• Exhibit 81: Arobella Medical LLC - Overview
• Exhibit 82: Arobella Medical LLC - Product / Service
• Exhibit 83: Arobella Medical LLC - Key offerings
• 11.4 B.Braun SE
• Exhibit 84: B.Braun SE - Overview
• Exhibit 85: B.Braun SE - Business segments
• Exhibit 86: B.Braun SE - Key news
• Exhibit 87: B.Braun SE - Key offerings
• Exhibit 88: B.Braun SE - Segment focus
• 11.5 Bioventus LLC
• Exhibit 89: Bioventus LLC - Overview
• Exhibit 90: Bioventus LLC - Business segments
• Exhibit 91: Bioventus LLC - Key news
• Exhibit 92: Bioventus LLC - Key offerings
• Exhibit 93: Bioventus LLC - Segment focus
• 11.6 Coloplast AS
• Exhibit 94: Coloplast AS - Overview
• Exhibit 95: Coloplast AS - Business segments
• Exhibit 96: Coloplast AS - Key news
• Exhibit 97: Coloplast AS - Key offerings
• Exhibit 98: Coloplast AS - Segment focus
• 11.7 ConvaTec Group Plc
• Exhibit 99: ConvaTec Group Plc - Overview
• Exhibit 100: ConvaTec Group Plc - Product / Service
• Exhibit 101: ConvaTec Group Plc - Key news
• Exhibit 102: ConvaTec Group Plc - Key offerings
• 11.8 Integra Lifesciences Corp.
• Exhibit 103: Integra Lifesciences Corp. - Overview
• Exhibit 104: Integra Lifesciences Corp. - Business segments
• Exhibit 105: Integra Lifesciences Corp. - Key news
• Exhibit 106: Integra Lifesciences Corp. - Key offerings
• Exhibit 107: Integra Lifesciences Corp. - Segment focus
• 11.9 Labomar S.p.A
• Exhibit 108: Labomar S.p.A - Overview
• Exhibit 109: Labomar S.p.A - Product / Service
• Exhibit 110: Labomar S.p.A - Key offerings
• 11.10 Lohmann and Rauscher GmbH and Co. KG
• Exhibit 111: Lohmann and Rauscher GmbH and Co. KG - Overview
• Exhibit 112: Lohmann and Rauscher GmbH and Co. KG - Product / Service
• Exhibit 113: Lohmann and Rauscher GmbH and Co. KG - Key offerings
• 11.11 Medaxis AG
• Exhibit 114: Medaxis AG - Overview
• Exhibit 115: Medaxis AG - Product / Service
• Exhibit 116: Medaxis AG - Key offerings
• 11.12 Mediwound Ltd.
• Exhibit 117: Mediwound Ltd. - Overview
• Exhibit 118: Mediwound Ltd. - Product / Service
• Exhibit 119: Mediwound Ltd. - Key offerings
• 11.13 Medline Industries LP
• Exhibit 120: Medline Industries LP - Overview
• Exhibit 121: Medline Industries LP - Product / Service
• Exhibit 122: Medline Industries LP - Key offerings
• 11.14 Molnlycke Health Care AB
• Exhibit 123: Molnlycke Health Care AB - Overview
• Exhibit 124: Molnlycke Health Care AB - Product / Service
• Exhibit 125: Molnlycke Health Care AB - Key offerings
• 11.15 Pulsecare Medical LLC
• Exhibit 126: Pulsecare Medical LLC - Overview
• Exhibit 127: Pulsecare Medical LLC - Product / Service
• Exhibit 128: Pulsecare Medical LLC - Key offerings
• 11.16 Smith and Nephew plc
• Exhibit 129: Smith and Nephew plc - Overview
• Exhibit 130: Smith and Nephew plc - Business segments
• Exhibit 131: Smith and Nephew plc - Key news
• Exhibit 132: Smith and Nephew plc - Key offerings
• Exhibit 133: Smith and Nephew plc - Segment focus
• 11.17 Zimmer Biomet Holdings Inc.
• Exhibit 134: Zimmer Biomet Holdings Inc. - Overview
• Exhibit 135: Zimmer Biomet Holdings Inc. - Business segments
• Exhibit 136: Zimmer Biomet Holdings Inc. - Key news
• Exhibit 137: Zimmer Biomet Holdings Inc. - Key offerings
• Exhibit 138: Zimmer Biomet Holdings Inc. - Segment focus

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
• Exhibit 139: Inclusions checklist
• Exhibit 140: Exclusions checklist
• 12.3 Currency conversion rates for US$
• Exhibit 141: Currency conversion rates for US$
• 12.4 Research methodology
• Exhibit 142: Research methodology
• Exhibit 143: Validation techniques employed for market sizing
• Exhibit 144: Information sources
• 12.5 List of abbreviations
• Exhibit 145: List of abbreviations